Pär Matsson

Platform Scientific Director – Drug Discovery and Development, University of Gothenburg

Key Publications
Conformational dynamics in the membrane interactions of bispecific targeted degrader therapeutics
2025
Structural dynamics of therapeutic nucleic acids with phosphorothioate backbone modifications
NAR Genomics and Bioinformatics, 2024
Challenges in Permeability Assessment for Oral Drug Product Development
Pharmaceutics, 2023
Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes
Molecular Pharmaceutics, 2021
A Cell-Free Approach Based on Phospholipid Characterization for Determination of the Cell Specific Unbound Drug Fraction (fu,cell)
Pharmaceutical Research, 2019

My research is centered on the development of new computational and experimental methods to simulate, quantitate and visualize drug distribution at the tissue, cellular and subcellular scales, and on applying these methods to understand how the chemical features of drug molecules determine their cellular transport, subcellular distribution and target engagement. My research interests also include how ligands outside the traditional small-molecule chemical space—oligonucleotides, PROTACs, macrocycles and other classes of large bioactive molecules—can be successfully developed into drugs.

Group members

Emma Inganäs-Söderlund
MyLan Eklund
Antonio Carlesso
Ruwei Yao
Abhimanyu Thakur
Zdenek Vavrina (external)
Merran Bryford (external)
Parisa Rabieifar (external)

Last updated: 2024-07-04

Content Responsible: Hampus Pehrsson Ternström(hampus.persson@scilifelab.uu.se)

Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.